Regenerative Therapies for Osteoarthritis Market Report

Global Regenerative Therapies for Osteoarthritis Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 03, 2022
  • PAGES：224
  • REPORT CODE：GMM795652
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Regenerative Therapies for Osteoarthritis market report explains the definition, types, applications, major countries, and major players of the Regenerative Therapies for Osteoarthritis market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Acelity

    • Organovo

    • Astellas Pharma

    • Athersys

    • Sanofi

    • Cytori Therapeutics

    • Orgenesis

    • Nuo Therapeutics

    • Mesoblast

    • Shire

    By Type:

    • Cell Therapy

    • Tissue Engineering

    • Gene Therapy

    By End-User:

    • Hospitals

    • Ambulatory Surgical Centers

    • Orthopaedic Clinics

    • Research Institutes

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Regenerative Therapies for Osteoarthritis Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Regenerative Therapies for Osteoarthritis Outlook to 2028- Original Forecasts

    • 2.2 Regenerative Therapies for Osteoarthritis Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Regenerative Therapies for Osteoarthritis Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Regenerative Therapies for Osteoarthritis Market- Recent Developments

    • 6.1 Regenerative Therapies for Osteoarthritis Market News and Developments

    • 6.2 Regenerative Therapies for Osteoarthritis Market Deals Landscape

    7 Regenerative Therapies for Osteoarthritis Raw Materials and Cost Structure Analysis

    • 7.1 Regenerative Therapies for Osteoarthritis Key Raw Materials

    • 7.2 Regenerative Therapies for Osteoarthritis Price Trend of Key Raw Materials

    • 7.3 Regenerative Therapies for Osteoarthritis Key Suppliers of Raw Materials

    • 7.4 Regenerative Therapies for Osteoarthritis Market Concentration Rate of Raw Materials

    • 7.5 Regenerative Therapies for Osteoarthritis Cost Structure Analysis

      • 7.5.1 Regenerative Therapies for Osteoarthritis Raw Materials Analysis

      • 7.5.2 Regenerative Therapies for Osteoarthritis Labor Cost Analysis

      • 7.5.3 Regenerative Therapies for Osteoarthritis Manufacturing Expenses Analysis

    8 Global Regenerative Therapies for Osteoarthritis Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Regenerative Therapies for Osteoarthritis Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Regenerative Therapies for Osteoarthritis Export by Region (Top 10 Countries) (2017-2028)

    9 Global Regenerative Therapies for Osteoarthritis Market Outlook by Types and Applications to 2022

    • 9.1 Global Regenerative Therapies for Osteoarthritis Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Cell Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Tissue Engineering Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Gene Therapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Regenerative Therapies for Osteoarthritis Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Orthopaedic Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Research Institutes Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Regenerative Therapies for Osteoarthritis Market Analysis and Outlook till 2022

    • 10.1 Global Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.2.2 Canada Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.2.3 Mexico Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.3.2 UK Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.3.3 Spain Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.3.4 Belgium Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.3.5 France Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.3.6 Italy Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.3.7 Denmark Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.3.8 Finland Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.3.9 Norway Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.3.10 Sweden Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.3.11 Poland Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.3.12 Russia Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.3.13 Turkey Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.4.2 Japan Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.4.3 India Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.4.4 South Korea Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.4.5 Pakistan Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.4.6 Bangladesh Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.4.7 Indonesia Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.4.8 Thailand Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.4.9 Singapore Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.4.10 Malaysia Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.4.11 Philippines Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.4.12 Vietnam Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.5.2 Colombia Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.5.3 Chile Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.5.4 Argentina Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.5.5 Venezuela Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.5.6 Peru Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.5.7 Puerto Rico Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.5.8 Ecuador Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.6.2 Kuwait Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.6.3 Oman Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.6.4 Qatar Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.7.2 South Africa Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.7.3 Egypt Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.7.4 Algeria Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

      • 10.8.2 New Zealand Regenerative Therapies for Osteoarthritis Consumption (2017-2022)

    11 Global Regenerative Therapies for Osteoarthritis Competitive Analysis

    • 11.1 Acelity

      • 11.1.1 Acelity Company Details

      • 11.1.2 Acelity Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Acelity Regenerative Therapies for Osteoarthritis Main Business and Markets Served

      • 11.1.4 Acelity Regenerative Therapies for Osteoarthritis Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Organovo

      • 11.2.1 Organovo Company Details

      • 11.2.2 Organovo Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Organovo Regenerative Therapies for Osteoarthritis Main Business and Markets Served

      • 11.2.4 Organovo Regenerative Therapies for Osteoarthritis Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Astellas Pharma

      • 11.3.1 Astellas Pharma Company Details

      • 11.3.2 Astellas Pharma Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Astellas Pharma Regenerative Therapies for Osteoarthritis Main Business and Markets Served

      • 11.3.4 Astellas Pharma Regenerative Therapies for Osteoarthritis Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Athersys

      • 11.4.1 Athersys Company Details

      • 11.4.2 Athersys Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Athersys Regenerative Therapies for Osteoarthritis Main Business and Markets Served

      • 11.4.4 Athersys Regenerative Therapies for Osteoarthritis Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Sanofi

      • 11.5.1 Sanofi Company Details

      • 11.5.2 Sanofi Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Sanofi Regenerative Therapies for Osteoarthritis Main Business and Markets Served

      • 11.5.4 Sanofi Regenerative Therapies for Osteoarthritis Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Cytori Therapeutics

      • 11.6.1 Cytori Therapeutics Company Details

      • 11.6.2 Cytori Therapeutics Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Cytori Therapeutics Regenerative Therapies for Osteoarthritis Main Business and Markets Served

      • 11.6.4 Cytori Therapeutics Regenerative Therapies for Osteoarthritis Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Orgenesis

      • 11.7.1 Orgenesis Company Details

      • 11.7.2 Orgenesis Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Orgenesis Regenerative Therapies for Osteoarthritis Main Business and Markets Served

      • 11.7.4 Orgenesis Regenerative Therapies for Osteoarthritis Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Nuo Therapeutics

      • 11.8.1 Nuo Therapeutics Company Details

      • 11.8.2 Nuo Therapeutics Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Nuo Therapeutics Regenerative Therapies for Osteoarthritis Main Business and Markets Served

      • 11.8.4 Nuo Therapeutics Regenerative Therapies for Osteoarthritis Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Mesoblast

      • 11.9.1 Mesoblast Company Details

      • 11.9.2 Mesoblast Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Mesoblast Regenerative Therapies for Osteoarthritis Main Business and Markets Served

      • 11.9.4 Mesoblast Regenerative Therapies for Osteoarthritis Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Shire

      • 11.10.1 Shire Company Details

      • 11.10.2 Shire Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Shire Regenerative Therapies for Osteoarthritis Main Business and Markets Served

      • 11.10.4 Shire Regenerative Therapies for Osteoarthritis Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Regenerative Therapies for Osteoarthritis Market Outlook by Types and Applications to 2028

    • 12.1 Global Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Tissue Engineering Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Gene Therapy Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Orthopaedic Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Regenerative Therapies for Osteoarthritis Market Analysis and Outlook to 2028

    • 13.1 Global Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.2.2 Canada Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.3.2 UK Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.3.3 Spain Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.3.5 France Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.3.6 Italy Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.3.8 Finland Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.3.9 Norway Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.3.11 Poland Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.3.12 Russia Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.4.2 Japan Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.4.3 India Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.5.3 Chile Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.5.6 Peru Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.6.3 Oman Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Regenerative Therapies for Osteoarthritis Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Regenerative Therapies for Osteoarthritis

    • Figure of Regenerative Therapies for Osteoarthritis Picture

    • Table Global Regenerative Therapies for Osteoarthritis Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Regenerative Therapies for Osteoarthritis Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Cell Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Tissue Engineering Consumption and Growth Rate (2017-2022)

    • Figure Global Gene Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Orthopaedic Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Research Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Regenerative Therapies for Osteoarthritis Consumption by Country (2017-2022)

    • Table North America Regenerative Therapies for Osteoarthritis Consumption by Country (2017-2022)

    • Figure United States Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Canada Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Mexico Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Table Europe Regenerative Therapies for Osteoarthritis Consumption by Country (2017-2022)

    • Figure Germany Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure UK Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Spain Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Belgium Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure France Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Italy Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Denmark Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Finland Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Norway Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Sweden Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Poland Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Russia Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Turkey Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Table APAC Regenerative Therapies for Osteoarthritis Consumption by Country (2017-2022)

    • Figure China Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Japan Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure India Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure South Korea Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Thailand Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Singapore Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Philippines Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Table South America Regenerative Therapies for Osteoarthritis Consumption by Country (2017-2022)

    • Figure Brazil Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Colombia Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Chile Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Argentina Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Peru Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Table GCC Regenerative Therapies for Osteoarthritis Consumption by Country (2017-2022)

    • Figure Bahrain Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Oman Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Qatar Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Table Africa Regenerative Therapies for Osteoarthritis Consumption by Country (2017-2022)

    • Figure Nigeria Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure South Africa Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Egypt Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Algeria Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Table Oceania Regenerative Therapies for Osteoarthritis Consumption by Country (2017-2022)

    • Figure Australia Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Regenerative Therapies for Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Table Acelity Company Details

    • Table Acelity Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acelity Regenerative Therapies for Osteoarthritis Main Business and Markets Served

    • Table Acelity Regenerative Therapies for Osteoarthritis Product Portfolio

    • Table Organovo Company Details

    • Table Organovo Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Organovo Regenerative Therapies for Osteoarthritis Main Business and Markets Served

    • Table Organovo Regenerative Therapies for Osteoarthritis Product Portfolio

    • Table Astellas Pharma Company Details

    • Table Astellas Pharma Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Regenerative Therapies for Osteoarthritis Main Business and Markets Served

    • Table Astellas Pharma Regenerative Therapies for Osteoarthritis Product Portfolio

    • Table Athersys Company Details

    • Table Athersys Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Athersys Regenerative Therapies for Osteoarthritis Main Business and Markets Served

    • Table Athersys Regenerative Therapies for Osteoarthritis Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Regenerative Therapies for Osteoarthritis Main Business and Markets Served

    • Table Sanofi Regenerative Therapies for Osteoarthritis Product Portfolio

    • Table Cytori Therapeutics Company Details

    • Table Cytori Therapeutics Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cytori Therapeutics Regenerative Therapies for Osteoarthritis Main Business and Markets Served

    • Table Cytori Therapeutics Regenerative Therapies for Osteoarthritis Product Portfolio

    • Table Orgenesis Company Details

    • Table Orgenesis Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Orgenesis Regenerative Therapies for Osteoarthritis Main Business and Markets Served

    • Table Orgenesis Regenerative Therapies for Osteoarthritis Product Portfolio

    • Table Nuo Therapeutics Company Details

    • Table Nuo Therapeutics Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nuo Therapeutics Regenerative Therapies for Osteoarthritis Main Business and Markets Served

    • Table Nuo Therapeutics Regenerative Therapies for Osteoarthritis Product Portfolio

    • Table Mesoblast Company Details

    • Table Mesoblast Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mesoblast Regenerative Therapies for Osteoarthritis Main Business and Markets Served

    • Table Mesoblast Regenerative Therapies for Osteoarthritis Product Portfolio

    • Table Shire Company Details

    • Table Shire Regenerative Therapies for Osteoarthritis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Regenerative Therapies for Osteoarthritis Main Business and Markets Served

    • Table Shire Regenerative Therapies for Osteoarthritis Product Portfolio

    • Figure Global Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tissue Engineering Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gene Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Orthopaedic Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Regenerative Therapies for Osteoarthritis Consumption Forecast by Country (2022-2028)

    • Table North America Regenerative Therapies for Osteoarthritis Consumption Forecast by Country (2022-2028)

    • Figure United States Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Regenerative Therapies for Osteoarthritis Consumption Forecast by Country (2022-2028)

    • Figure Germany Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Regenerative Therapies for Osteoarthritis Consumption Forecast by Country (2022-2028)

    • Figure China Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Regenerative Therapies for Osteoarthritis Consumption Forecast by Country (2022-2028)

    • Figure Brazil Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Regenerative Therapies for Osteoarthritis Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Regenerative Therapies for Osteoarthritis Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Regenerative Therapies for Osteoarthritis Consumption Forecast by Country (2022-2028)

    • Figure Australia Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Regenerative Therapies for Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US